204 Million People Worldwide Are Affected by Atopic Dermatitis

Apr 10, 2026 | Newsletters

  • Nexus Wise
  • $
  • 204 Million People Worldwide Are Affected by Atopic Dermatitis
nw 204 million people worldwide are affected by atopic dermatitis 01

Atopic dermatitis affects an estimated 204 million people worldwide, creating growing demand for differentiated skin health solutions. This makes eczema an attractive category for brands looking for new product innovation.

Developed from Tenggek Burung, ECZEFOLIA® is a clean label plant-based solution designed for ingredient suppliers and brand holders looking to build an inside-out skin health story without steroids. It is suitable for supplement and functional food innovation across multiple formats.

 

ECZEFOLIA® gives ingredient suppliers and brand holders a fresh opportunity with a clinically studied plant extract positioned as the world’s first oral eczema ingredient for health supplements.

 

Why ECZEFOLIA® stands out

World’s first oral eczema positioning

Plant-based and steroid-free concept

Suitable for capsules, tablets, and powder formats

Helps ingredient suppliers and brand holders create stronger differentiation in skin health portfolios

 

Early differentiation often helps ingredient suppliers and brand holders attract faster buyer interest. Reply now to request a sample.

Send us a message.

Contact Us Form

Hi, we are raw material ingredients solution provider and do not have any finished products any the moment. Nice talking to you!

We’ll help you find the right products and pricing for your business. Tell us a bit about yourself, and we’ll get in touch as soon as we can.

Our help center is fresh and always open for business. If you can’t find the answer you’re looking for, we’re here to lend a hand.

How can we help you? The more details, the better!

Stay up to date on Nexus Wise news.